Reproducibility of the NMR-based quantitative metabolomics and HBV-caused changes in human serum lipoprotein subclasses and small metabolites

Qingxia Huang; Qinsheng Chen; Xiaoxuan Yi; Huan Wang; Qi Wang; Haijuan Zhi; Junfang Wu; Dao Wen Wang; Huiru Tang

doi:10.1016/j.jpha.2024.101180

Volume 15 Issue 7

Jul. 2025

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2025 > 15(7): 101180

Qingxia Huang, Qinsheng Chen, Xiaoxuan Yi, Huan Wang, Qi Wang, Haijuan Zhi, Junfang Wu, Dao Wen Wang, Huiru Tang. Reproducibility of the NMR-based quantitative metabolomics and HBV-caused changes in human serum lipoprotein subclasses and small metabolites[J]. Journal of Pharmaceutical Analysis, 2025, 15(7): 101180. doi: 10.1016/j.jpha.2024.101180

Citation:

Qingxia Huang, Qinsheng Chen, Xiaoxuan Yi, Huan Wang, Qi Wang, Haijuan Zhi, Junfang Wu, Dao Wen Wang, Huiru Tang. Reproducibility of the NMR-based quantitative metabolomics and HBV-caused changes in human serum lipoprotein subclasses and small metabolites[J]. Journal of Pharmaceutical Analysis, 2025, 15(7): 101180. doi: 10.1016/j.jpha.2024.101180

Citation:

Qingxia Huang, Qinsheng Chen, Xiaoxuan Yi, Huan Wang, Qi Wang, Haijuan Zhi, Junfang Wu, Dao Wen Wang, Huiru Tang. Reproducibility of the NMR-based quantitative metabolomics and HBV-caused changes in human serum lipoprotein subclasses and small metabolites[J]. Journal of Pharmaceutical Analysis, 2025, 15(7): 101180. doi: 10.1016/j.jpha.2024.101180

PDF( 930 KB)

Reproducibility of the NMR-based quantitative metabolomics and HBV-caused changes in human serum lipoprotein subclasses and small metabolites

doi: 10.1016/j.jpha.2024.101180

a. State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Metabonomics and Systems Biology Laboratory at Shanghai International Centre for Molecular Phenomics, Zhongshan Hospital, Fudan University, Shanghai, 200032, China;
b. Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China;
c. Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, 430000, China

Funds:

We acknowledge financial supports from the National Key R&

D Program of China (Grant Nos.: 2022YFC3400700 and 2022YFA0806400), the Shanghai Municipal Science and Technology Major Project, China (Grant No.: 2017SHZDZX01), and the National Natural Science Foundation of China (Grant No.: 31821002).

Received Date: May 12, 2024
Accepted Date: Dec. 29, 2024
Rev Recd Date: Dec. 24, 2024
Available Online: Aug. 15, 2025
Publish Date: Dec. 31, 2024

Abstract

FullText(HTML)

References(5)

References

[1]	M. Xia, H. Zeng, S. Wang, et al., Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling, J. Hepatol. 74 (2021) 974-977.
[2]	R.L. Loo, S. Lodge, T. Kimhofer, et al., Quantitative in-vitro diagnostic NMR spectroscopy for lipoprotein and metabolite measurements in plasma and serum: Recommendations for analytical artifact minimization with special reference to COVID-19/SARS-CoV-2 samples, J. Proteome Res. 19 (2020) 4428-4441.
[3]	B. Jimenez, E. Holmes, C. Heude, et al., Quantitative lipoprotein subclass and low molecular weight metabolite analysis in human serum and plasma by 1H NMR spectroscopy in a multilaboratory trial, Anal. Chem. 90 (2018) 11962-11971.
[4]	J. Pinto, E. Galhano, et al., Human plasma stability during handling and storage: Impact on NMR metabolomics, Analyst 139 (2014) 1168-1177.
[5]	D. Zuo, H. An, J. Li, et al., The application value of lipoprotein particle numbers in the diagnosis of HBV-related hepatocellular carcinoma with BCLC stage 0-A, J. Pers. Med. 11 (2021) 1143.